Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IRON | US
0.53
0.78%
Healthcare
Biotechnology
30/06/2024
24/04/2026
68.85
68.32
69.92
67.11
Disc Medicine Opco Inc together with its subsidiaries operates as a clinical-stage biotechnology company engages in the discovery development and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company builds a portfolio of fundamental biological pathways of red blood cell biology primarily heme biosynthesis and iron homeostasis. It also develops bitopertin for the treatment of erythropoietic porphyrias erythropoietic protoporphyria and X-linked protoporphyria. In addition the company develops DISC-0974 for the treatment of chronic kidney disease; MWTX-003 for the treatment of polycythemia vera and other hematologic disorders; and DISC-0998 for the treatment of anemia associated with inflammatory. The company is based in Watertown Massachusetts.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Price Below SMA10D
Midcap (2B - 10B USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
35.3%1 month
36.6%3 months
71.2%6 months
59.5%-
-
3.07
0.00
0.00
-7.56
-
-
-110.80M
2.05B
2.05B
-
-
-
-
-21.16
8.00
6.08
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
6.94
Range1M
14.05
Range3M
43.93
Rel. volume
0.64
Price X volume
15.04M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Spruce Biosciences Inc | SPRB | Biotechnology | 54.37 | 2.25B | 0.67% | n/a | 6.24% |
| BEAM THERAPEUTICS INC. | BEAM | Biotechnology | 27.11 | 2.23B | -10.11% | n/a | 19.35% |
| Ultragenyx Pharmaceutical Inc | RARE | Biotechnology | 24.1 | 2.22B | -0.74% | n/a | 214.27% |
| Celldex Therapeutics Inc | CLDX | Biotechnology | 33.29 | 2.21B | -0.77% | n/a | 0.29% |
| DBV Technologies S.A | DBVT | Biotechnology | 19.8 | 2.11B | 2.38% | n/a | 16.59% |
| ELVN | ELVN | Biotechnology | 44.25 | 2.09B | 0.82% | n/a | 0.06% |
| Adeptus Health Inc | ADPT | Biotechnology | 14.14 | 2.09B | 2.32% | n/a | 93.65% |
| Sol-Gel Technologies Ltd | SLGL | Biotechnology | 74.83 | 2.08B | 3.50% | n/a | 3.99% |
| Vera Therapeutics Inc. Class A Common Stock | VERA | Biotechnology | 37.69 | 2.07B | -1.82% | n/a | 16.11% |
| Zymeworks Inc | ZYME | Biotechnology | 28.1 | 2.00B | 2.44% | n/a | 4.94% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| HNI Corporation | HNI | Building Products & Equipment | 37.7 | 1.78B | 1.32% | 22.12 | 76.47% |
| ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 14.6 | 1.46B | 3.03% | n/a | 19.46% |
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 39.11 | 1.23B | -1.21% | 51.60 | 88.92% |
| Winnebago Industries Inc | WGO | Recreational Vehicles | 32.87 | 951.75M | 0.70% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.44 | 790.55M | 1.30% | 11.62 | 116.21% |
| Fox Factory Holding Corp | FOXF | Recreational Vehicles | 17.7 | 737.79M | 2.31% | 42.05 | 64.69% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 6.01 | 694.62M | -0.17% | 65.18 | 77.00% |
| Ennis Inc | EBF | Building Products & Equipment | 20.33 | 528.66M | -1.26% | 13.28 | 2.28% |
| Malibu Boats Inc | MBUU | Recreational Vehicles | 26.1 | 521.76M | -0.91% | n/a | 1.50% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 23.53 | 390.77M | -0.88% | 34.27 | 26.82% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -7.56 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.07 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 71.22 | - | Par |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 2.05B | - | Emerging |